Cytoplasmic acetoacetyl-CoA thiolase (acetyl-CoA-acetyl-CoA C-aoetyltransferase, EC 2.3.1.9) was partially purified from rat liver. The enzyme was irreversibly inactivated by 4-bromocrotonyl-CoA, but-3-ynoyl-CoA, pent-3-ynoyl-CoA and dec-3-ynoyl-CoA.
synthesis, they have the disadvantage common to many halogenated compounds of being too reactive, and this would lead to inhibition of numerous enzymes. Holland et al. (1973a) have developed the acetylenic compounds, alk-3-ynoyl-CoA esters, to alkylate the enzyme. The alk-3-ynoyl-CoA esters inactivate 3-ketoacyl-CoA thiolase by a mechanism which appears uniquely suitable for a specific alkylating agent. Thus alk-3-ynoyl-CoA esters are not highly reactive in their own right. Rather, they are converted by active 3-ketoacyl-CoA thiolase into the alka-2,3-dienoyl-CoA, which then readily inactivates the enzyme. Thus the enzyme catalyses its own inactivation. A number of acetylenic compounds have now been used as alkylating inhibitors of a variety of enzymes. The enzyme-catalysed isomerization of the acetylenic bond to an allene before inactivation appears to be a common feature of the inactivation mechanism (Endo etaL., 1970; Morisaki & Bloch, 1972 ; Abeles & Walsh, 1973; Hevey etal., 1973) . This feature suggests that suitably designed acetylenic compounds may have significant pharmacological applications. In the present work it is shown that alk-3-ynoyl-CoA esters are effective alkylating inhibitors of hepatic cytosolic acetoacetylCoA thiolase and that this results in a selective inhibition of cholesterol biosynthesis between acetate and mevalonate. A preliminary report of this work has been presented (Bloxham, 1974 Centre, Amersham, Bucks., U.K. Dec-3-yn-1-ol, oct-3-yn-1-ol and hex-3-yn-1-ol were synthesized by the addition ofethylene oxide to the Grignard reagent of the appropriate 1-alkyne (Knight & Diamond, 1959) . But-3-yn-1-ol was obtained from Ralph N. Emanuel Ltd., Wembley, Middx., U.K. The purity and structure ofeach acetylenic alcohol was confirmed by g.l.c. followed by mass spectrometry. In each case the alcohols were free of starting material and the expected molecular ion and fragmentation pattern were observed. The acetylenic alcohols were oxidized to their corresponding acids with CrO3 in H2SO4 (Heilbron et al., 1949) . 4-Bromocrotonic acid was prepared by refluxing crotonic acid with N-bromosuccinimide in the presence of benzoyl peroxide (Bradshaw et al., 1969) . Oxalyl chloride was used to convert carboxylic acids into their acid chlorides, which were subsequently used to acylate CoA (Holland et al., 1973a) . Acyl thioester concentrations were determined by the ferric hydroxamate method of Lipmann & Tuttle (1945) . Acetoacetyl-CoA was prepared by the treatment of CoA with diketen in 0.1 M-KHCO3. The concentration ofacetoacetyl-CoA was assayed with pig heart f-hydroxybutyryl-CoA dehydrogenase obtained from Sigma (London) Chemical Co., London S.W.6, U.K. (Lynen & Wieland, 1955) .
Hepatic cytoplasmic acetoacetyl-CoA thiolase A partially purified preparation of hepatic cytoplasmic acetoacetyl-CoA thiolase was prepared from rat liver by modification of a procedure described by Middleton (1973) . In this procedure, the cytosolic enzyme is eluted from a DEAE-cellulose column by a gradient of 0.1-0.5M-Tris-HCI, pH8.2, containing 10% (v/v) (Lynen et al., 1952) .
Incorporation ofradioactive preclursors into sterols and fatty acids Postmitochondrial supernatants from rat liver were prepared in 0.25M-sucrose containing 50mM-potassium phosphate, pH7.4, 25mM-KCl and IOmM-MgCI2. Postmitochondrial supernatant fractions (0.7ml; 6-8mg of protein) were incubated in a volume of 1 ml with IOmM-KHCO3, 1 mM-NADP+, 2.5mM-ATP, 5mM-glucose 6-phosphate and either sodium [2-'4C]acetate (2,uCi) or [2-3H2]mevalonate (1 Ci). Incubations were performed in 15ml centrifuge tubes at 37°C for 15min. The reaction was terminated by the addition of 2ml of methanolic 20 % (w/v) KOH. After being hydrolysed at 80°C for 5min, the total sterols were extracted into light petroleum (b.p. 60-80'C)-diethyl ether (1:1, v/v) . For analysis ofcholesterol synthesis, radioactive cholesterol was isolated as the 5,6-dibromide derivative (Akhtar et al., 1969) . To isolate fatty acids, the aqueous phase remaining after the sterol extraction was cooled on ice and carefully acidified with conc. HCl. Fatty acids were thenextracted with 3 x 3ml of light petroleum (b.p. 60-80C)-diethyl ether (1:1, v/v). The organic extracts were pooled and their volume decreased to 1 ml. This was mixed thoroughly with 1 ml of 5 % (w/v) KOH. The organic phase was discarded and the aqueous phase washed three times with diethyl ether. After acidification of the aqueous phase, the total fatty acids were extracted with 3 x 2ml of light petroleum-diethyl ether (1:1, v/v), and the sample radioactivity was determined.
Liquid-scintillation counting of radioactive samples was performed as described previously .
Pr eparation and assay offatty acyl-CoA synthetase Freeze-dried microsomal fractions from rat liver wereprepared by themethod ofBar- Tana et al. (1971) . Microsomal fractions (3mg) were incubated at 38°C in 0.35ml of 0.1 M-Tris-HCl, pH7.4, containing 0.2% (w/v) Triton X-100, 1.5mM-EDTA, 35mM-MgCl2, 10mM-fatty acid under test and 1 mM-CoA. At appropriate times 50,cl samples were removed and the free thiol content was assayed by using 1 ml of 0.5mM-5,5'-dithiobis-(2-nitrobenzoic acid) (Ellman, 1959) in 0.1M-potassium phosphate buffer, pH8.0. For the fatty acyl-CoA synthetase the activity was assumed to equal the rate of CoA disappearance. 1975 3-Ketoacyl-CoA thiolase from many tissues can be separated into distinct isoenzymes on the basis of either the physical properties of the enzyme or by its intracellular location (Middleton, 1973; Clinkenbeard et al., 1973) . The original studies on the alkylating properties of alk-3-ynoyl-CoA esters were performed with a mitochondrial' isoenzyme of 3-ketoacyl-CoA thiolase isolated from pig heart (Holland et al., 1973a) . This is a distinct isoenzyme from the hepatic cytosolic isoenzyme (Middleton, 1973) which participates in the condensation of acetyl-CoA in cholesterol biosynthesis. Ifalk-3-ynoylCoA esters are to be effective inhibitors of cholesterol synthesis then they would be required to inactivate the cytosolic isoenzyme. Thus an initial part of this project was to evaluate the sensitivity of the cytosolic acetoacetyl-CoA thiolase to alk-3-ynoyl-CoA esters. For the alkylation studies, hepatic cytoplasmic acetoacetyl-CoA thiolase was separated from any contaminating mitochondrial 3-ketoacyl-CoA thiolase by chromatography on DEAE-cellulose (Middleton, 1973) .
The catalytic mechanism of 3-ketoacyl-CoA thiolase involves the generation of an enzyme-bound acetyl group which requires the participation of an essential thiol residue. Previous studies with heart mitochondrial 3-ketoacyl CoA thiolase (Lynen, 1953; Gehring et al., 1968; Gehring & Harris, 1970) and liver cytosolic acetoacetyl-CoA thiolase (Middleton, 1974) have shown that the enzyme is readily inactivated by reaction of the active-site thiol with iodoacetamide. To test the reactivity of the active-site thiol in cytosolic acetoacetyl-CoA thiolase, the effect of 4-bromocrotonyl-CoA was tested. 4-Bromocrotonyl-CoA reacts very readily with thiol groups (Holland et al., 1973a) . Fig. 1 shows that the partially purified cytoplasmic acetoacetyl-CoA thiolase is rapidly inactivated. Inactivation follows first-order kinetics when the concentration of alkylating inhibitor is varied over a twentyfold range. A double-reciprocal plot ofthe apparent rate constant for inactivation versus the inhibitor concentration was found to be linear (Kitz & Wilson, 1962) and enabled the estimation of the dissociation constant for the enzyme-inhibitor complex (K1, 2.75 x 10-4M) and a pseudo-first-order constant for inactivation (k3, 1.0min-1). Both of these values are somewhat higher than the comparable values for inactivation of heart mitochondrial 3-ketoacyl-CoA thiolase by 4-bromocrotonyl-CoA (K1, 1.25 x 10-M; k3, 0.50 min-'). By dividing k3 by KI it is possible to obtain an apparent value for a second-order rate constant for inactivation. For the alkylation of cytoplasmic acetoacetyl-CoA thiolase by 4-bromocrotonyl-CoA, a value of 60M-1'-s can be calculated. This value compares with a second-order rate constant of 96M-1 s-s which can be calculated from data for the reaction of 4-bromocrotonyl thioester with the cysteine in glutathione (Holland et al., 1973a) . The similarity of these two values indicates that the active-site thiol in cytoplasmic acetoacetyl-CoA thiolase is not unusually reactive.
Having established the characteristic response of cytoplasmic acetoacetyl-CoA thiolase to a thioldirected alkylating reagent, the effect of various alk-3-ynoyl-CoA esters was tested. The compounds used were but-3-ynoyl-CoA, pent-3-ynoyl-CoA and dec-3-ynoyl-CoA. Whereas the inactivation by pent-3-ynoyl-CoA and dec-3-ynoyl-CoA followed pseudo-first-order kinetics, the inactivation of hepatic cytoplasmic acetoacetyl-CoA thiolase by but-3-ynoyl-CoA could not be fitted to a first-order plot. Thus plots of log (percentage activity) versus time were curved once inactivation had proceeded beyond 50% inhibition of enzyme activity. This result indicates that the reaction follows a secondorder process. Similar results have also been noted for the reaction of heart mitochondrial 3-ketoacylCoA thiolase with iodoacetamide (Gehring et al., 1968) , bromoacetyl-CoA (Holland et al., 1973a ) and but-3-ynoyl-CoA (Holland et al., 1973a) . It is generally assumed that an active-site-directed inhibitor which follows first-order kinetics obeys the following general scheme (Kitz & Wilson, 1962) :
In this scheme it is assumed that the rate of inactivation is low compared with the establishment of a steady-state concentration of El which is essential if inactivation is to follow first-order kinetics. It must be presumed that for but-3-ynoyl-CoA, then k3 must be appreciably faster than for pent-3-ynoyl-CoA, dec-3-ynoyl-CoA or 4-bromocrotonyl-CoA.
To illustrate the marked difference in the alkylating properties of the three alk-3-ynoyl-CoA esters under test, the enzyme inactivation produced in a fixed time was measured at a variety of inhibitor concentrations (Fig. 2) . But-3-ynoyl-CoA is approximately a hundred times more potent than pent-3-ynoyl-CoA. This reflects the chain-length specificity ofcytoplasmic acetoacetyl-CoA thiolase for 3-ketoacyl-CoA esters, since acetoacetyl-CoA thiolase is known to use acetoacetyl-CoA (C4) in preference to longer-chain 3-ketoacyl-CoA esters (Middleton, 1973) . The main decrease in the affinity of cytoplasmic acetoacetylCoA thiolase for alk-3-ynoyl-CoA esters occurs when the substrate chain length is extended by one methyl from C4 to C5, and beyond this there is virtually no change. This is reflected in the fact that pent-3-ynoyl-CoA and dec-3-ynoyl-CoA have relatively similar potencies as inactivating agents of cytoplasmic acetoacetyl-CoA thiolase.
As will be shown below, dec-3-ynoyl-CoA appears to be a useful inhibitor of cholesterol synthesis, and its inhibitory properties were evaluated in slightly 1975 more detail. The inactivation of cytoplasmic acetoacetyl-CoA thiolase was found to follow first-order kinetics for loss of at least 90% of the enzyme activity. Fig. 3 shows that the rate of inactivation of acetoacetyl-CoA thiolase was dependent on the dec-3-ynoyl-CoA concentration. From this plot, the rate constant for inactivation was estimated at 0.25min-I and the dissociation constant was 170gm. The initial process in the inactivation mechanism presumably involves the formation of a binary complex between acetoacetyl-CoA thiolase and the alkylating agent. For dec-3-ynoyl-CoA, where the loss of activity is relatively slow at low concentrations of inhibitor then the formation of the inhibitory complex may be studied on the basis of the ability to interfere with the binding of substrate. To assess this action, dec-3-ynoyl-CoA was incubated with the enzyme and substrates under conditions when alkylation of the enzyme was minimum. This was achieved by commencing assays by the addition of enzyme to the complete reaction mixture and by following only the initial retion velocity in the first minute. Inactivation of the enzyme, as indicated by progressive slowing of the reaction rate, was only noted if the reaction was followed over longer periods of time. Fig. 4 shows that when the effect of dec-3-ynoyl-CoA on the activity of acetoaetyl-CoA thiolase is assayed directly then it is a competitive inhibitor with respect to acetoacetyl-CoA. The apparent dissociation constant for the binding of dec-3-ynoyl-CoA to acetoacetyl-CoA thiolase is 36gM. This value is somewhat lower than the dissociation constant (170gM) determined in the inactivation studies. This may reflect the more complex phenomenon required for inactivation, which may involve isomerization of the acetylene to the allene. The competitive nature ofthe binding ofdec-3-ynoyl-CoA with respect to acetoacetyl-CoA would be expected if the alkylating inhibitor binds to the enzym active site. It is known that inclusion of acetoacetyl-CoA in the inactivation incubation medium prevents inactivation of 3-ketoacyl-CoA thiolaw by alk-3-ynoylCoA esters (Holland et at., 1973a) .
Cholesterol synthesis
The experiments presented so far show that alk-3-ynoyl-CoA esters are effective inhibitors of cytoplasmic acetoacetyl-CoA thiolase Inhibition can occur either through an irreversible inactivation or as a result of competitive binding at the active site.
The influence of alk-3-ynoyl-CoA esters on cholesterol synthesis was studied by using postmitochondrial preparations from rat liver. When sodium [2-'4Clacetate was used as a precursor for sterol synthesis, the incorporation showed a lag for the first 5min, and beyond this time the rate of incorporation was constant. Vol. 147 were incubated directlywith the complete el1-frwpreparation for sterol synthesis and the incorporation of radioactivity into total sterols was measured after 15min at 37°C (see the Materials and Methods section). The results are the average of three separate experiments. For each experimental point the standard error was never greater than 10% of the mean. o, Dec-3-ynoyl-CoA; 0, pent-3-ynoyl-CoA; A, but-3-ynoyl-CoA.
When but-3-ynoyl-CoA, pent-3-ynoyl-CoA and dec-3-ynoyl-CoA were added directly to the incubation this resulted in an inhibition of incorporation. The demonstration of inhibition did not require a preliminary incubation of the postmitochondrial preparation with the inhibitor. The potency as inhibitors was a function of the chain length of the alk-3-ynoyl-CoA esters (Fig. 5) . However, it is clear that there is not the same degree of difference in the sensitivity to the alk-3-ynoyl-CoA esters as is observed in the alkylation experiments on isolated acotoacetyl-CoA thiolse, The similarity in pQtoncy is due predominantly to a decrease in the effectiveness of but-3-ynoyl-CoA. But-3-ynoyl-CoA has only limited stability at alkaline pH (Holland et al,, 1973a) , and it is presumed that the crude preparation required for sterol synthesis promotes its destruction. It was not possible to demonstrate directly that cholesterol synthesis was inhibited in an irreversible manner. However, when postmitochondrial fractions were incubated with alk-3-ynoyl-CoA esters then at the end of the incubation the demonstrable activity of acetoacetyl-CoA thiolase was decreased compared with the control.
As pointed out in the introduction, it is an aim of the development of specific inhibitors of cholesterol synthesis that they should not result in the accumulation of unwanted sterols. This should not be the case with the alk-3-ynoyl-CoA esters, which affect cholesterol synthesis at an early stage and which inhibit the accumulation of total sterols (Fig. 5) . To confirm that alk-3-ynoyl-CoA esters do not lead to an abnormal pattern of sterol synthesis, the total sterol synthesized from acetate in a control incubation was compared with the sterols synthesized in the presence of 50/uM-dec-3-ynoyl-CoA. The addition of dec-3-ynoyl-CoA gave 60% inhibition of total sterol synthesis. After t.l.c. in light petroleum (b.p. 60-80'C)-acetone (14: 3, v/v), three major sterols were identified, namely, cholesterol (RF, 0.33; 30% of total radioactivity), lanosterol (RF, 0.50; 10% of total radioactivity) and squalene (RF, 0.90; 60% of total radioactivity). The relative distribution of radioactivity in these three fractions was not significantly altered by the presence of dec-3-ynoyl-CoA.
The specificity of action of alk-3-ynoyl-CoA esters was examined by measuring their effect on the (Fig. 6) . It is apparent that dec-3-ynoyl-CoA caused a complete inhibition of sterol synthesis from acetate at concentrations which produced virtually no effect on mevalonate incorporation. This shows that the site of inhibition lies between acetate and mevalonate, which is the expected result for an inhibitor of acetoacetyl-CoA thiolase which is essential for the conversion of acetate into mevalonate. In accord with this proposal, Fig. 6 also shows that the inhibitory action of dec-3-ynoyl-CoA on the catalytic activity of acetoacetyl-CoA thiolase in the postmitochondrial supernatant closely parallels the inhibition of acetate incorporation into cholesterol. It may be noted that once alk-3-ynoyl-CoA ester concentrations exceed about 100puM there is an inhibition of mevalonate incorporation. This inhibition occurs with most of the parameters measured in this work and appears to be a non-specific action of the alk-3-ynoyl-CoA esters.
Further specificity of the action of alk-3-ynoyl-CoA esters is shown by the fact that when sterol synthesis from acetate is markedly inhibited, there is no equivalent inhibition of acetate incorporation into fatty acids (Fig. 6) . Indeed, for dec-3-ynoyl-CoA at low concentrations there appears to be some stimulation of incorporation. This stimulation was most prevalent with dec-3-ynoyl-CoA and was minimal with but-3-ynoyl-CoA and pent-3-ynoyl-CoA. This may indicate that dec-3-ynoyl-CoA is a substrate for the microsomal elongation process for fatty acid synthesis (Guchhait et al., 1966) . The absence of an inhibitory effect of alk-3-ynoyl-CoA esters on fatty acid synthesis is expected, since acetate incorporation into fatty acids involves the intermediacy of malonylCoA (Wakil, 1958) , and acetoacetyl-CoA thiolase is not involved in this process.
Experiments on pig heart 3-ketoacyl-CoA thiolase showed that only thioesters of alk-3-ynoic acids were effective alkylating inhibitors and that CoA esters were the most effective (Holland et al., 1973a) . If alk-3-ynoic acids are to inhibit cholesterol biosynthesis then they should first be activated to their CoA esters. The ability of a variety of alk-3-ynoic acids to inhibit sterol synthesis was tested (Fig. 7) . In postmitochondrial preparations, but-3-ynoic acid and pent-3-ynoic acid were completely without effect. As the chain length was increased beyond C5 then there was an increase in the inhibition of synthesis. Both hex-3-ynoic acid and oct-3-ynoic acid have similar effectiveness, but there is a marked increase in inhibitory potency with dec-3-ynoic acid. 404uM, which is comparable with but slightly higher than the value observed for dec-3-ynoyl-CoA (KI = 30pM). This result shows that dec-3-ynoic acid must be efficiently converted into the CoA ester. When using the free acid to inhibit sterol synthesis from acetate, there is the possibility that the alk-3-ynoic acid inhibits by virtue of CoA sequestration (Williamson et al., 1970 ). This does not appear to be the case here, since the simple fatty acid, decanoic acid, has virtually no effect on sterol synthesis (Fig. 7) . Further, the inclusion of CoA (5OuM) was not essential for the incorporation of acetate into cholesterol and neither did it prevent the inhibition produced by either dec-3-ynoic acid or dec-3-ynoylCoA.
In a postmitochondrial preparation, fatty acids will be converted into their CoA esters primarily by the microsomal fatty acyl-CoA synthetase (Kornberg & Pricer, 1953) . That this system is essential for the inhibitory action of alk-3-ynoic acids is reflected in the fact that the efficacy of the alk-3-ynoic acids in inhibiting sterol synthesis compares with the known chain-length specificity of the microsomal fatty acyl-CoA synthetase. The microsomal enzymes utilize C1O or C12 fattyacids preferentially and shorterchain acids are very poor substrates (Kornberg & Pricer, 1953 Freeze-dried microsomal fraction from rat liver was incubated in the presence of either dec-3-ynoic acid (0), or dodecanoic acid (A) and in the absence of fatty acid (El).
The esterification of CoA was measured on the basis of thiol disappearance. Duplicate analyses of thiol content agreed within 5%. The exact incubation conditions are described in the Materials and Methods section.
alk-3-ynoic acids. Thus but-3-ynoic acid is not a substrate, whereas dec-3-ynoic acid is a good substrate. Fig. 8 shows that the activity with dec-3-ynoic acid (70nmol/min per mg of microsomal protein) is approx. 30 % ofthe activity observed with dodecanoic acid (230nmol/min per mg of microsomal protein).
In the 1 ml incubation system used for cholesterol synthesis there are 2-3mg of microsomal protein.
This means that at a concentration of dec-3-ynoic acid equal to its apparent K1 (40M), the capacity of the microsomal-activating enzymes should be sufficient to achieve the rapid conversion of the acid into the CoA ester and this would produce the observed inhibition of synthesis.
Discussion
The results presented clearly indicate that alk-3-ynoyl-CoA esters are effective alkylating inhibitors of cytoplasmic acetoacetyl-CoA thiolase and that this action can lead to a selective inhibition of sterol synthesis in vitro between acetate and mevalonate. Although the inhibition of sterol synthesis can be correlated with the inhibition of acetoacetyl-CoA thiolase (cf. Fig. 6 ) it is not established whether inhibition of the enzyme in the postmitochondrial fraction is the result of alkylation or of direct inhibition of catalytic activity. In all probability inhibition results from a combination of the two processes, since it is found that the onset of inhibition is rapid (competitive inhibition of catalytic activity) and that if a postmitochondrial fraction is incubated with alk-3-ynoyl-CoA esters then at the end of the incubation the demonstrable activity of 3-ketoacylCoA thiolase is decreased compared with the control (alkylation). It is possible that sterol synthesis may be additionally inhibited by the alk-3-ynoyl-CoAdependent inhibition of I)-hydroxy-fi-methylglutarylCoA synthase (EC 4.1.3.5 ). This effect is feasible, since acetoacetyl-CoA thiolase and fi-hydroxy-fimethylglutaryl-CoA synthase catalyse analogous reactions and fi-hydroxy-fi-methylglutaryl-CoA synthase also has an essential thiol which participates in the catalytic reaction (Middleton & Tubbs, 1974) .
The experiments with alk-3-ynoyl-CoA esters also serve to establish the pathway for acetoacetyl-CoA formation in cholesterol biosynthesis. Occasionally, it has been suggested that this might occur through the condensation of acetyl-CoA with malonyl CoA as in the early stages of fatty acid synthesis (Brodie et al., 1963; Fimognari & Rodwell, 1970) . The observation that alk-3-ynoyl-CoA esters do not inhibit fatty acid synthesis, although they are potent inhibitors of cholesterol synthesis, shows that the synthesis of acetoacetyl-CoA for cholesterol can only proceed through acetoacetyl-CoA thiolase. This result reinforces the conclusions drawn from the isotopic studies of Higgins & Kekwick (1973) and the studies with inhibitors of acetyl-CoA carboxylase (Barth et al., 1973) .
At present, the action of the alk-3-ynoyl-CoA esters is limited to the system in vitro, and their potential as inhibitors of cholesterol synthesis in vivo is unknown. It seems obligatory that if these compounds are to have any effect in vivo then they will be administered as the free acid and that conversion into the reactive CoA ester will depend on intracellular activation. Within this context it seems unlikely that short-chain alk-3-ynoic acids will be effective on cytoplasmic acetoacetyl-CoA thiolase, since they are poor substrates for the microsomal fatty acyl.CoA synthetase. They have been tested with bovine liver mitochondrial short-chain fatty acyl-CoA synthetase (P. C. Holland & D. P. Bloxham, unpublished work) and found to be moderate substrates compared with hexadi-2,4-enoic acid (sorbic acid), which suggests that they might exert intramitochondrial effects. The longer-chain alk-3-ynoic acid, dec-3-ynoic acid, seems to be more promising, since it is a reasonable substrate for the microsomal fatty acyl-CoA synthetase and the CoA ester is an effective inhibitor of the enzyme. The observation that dec-3-ynoyl-CoA inhibits cytoplasmic acetoacetyl-CoA thiolase was unexpected, since this enzyme is known to use acetoacetyl-CoA preferentially and the catalytic activity with longer-chain 3-ketoacylCoA esters decreases markedly (Stern & Ochoa, 1956; Middleton, 1973) . The fact that inhibition is obtained with dec-3.ynoyl-CoA probably reflects the decreased restrictions for the formation of an enzyme-inhibitor complex compared with the formation of the catalytic enzyme-substrate complex.
On a general note, it is worthwhile considering why an enzyme such as cytoplasmic acetoacetyl-CoA thiolase should be chosen as a potential target for inhibition of cholesterol synthesis. Certainly, acetoacetyl-CoA thiolase is readily inhibited by suitably designed affinity labels, which is a distinct advantage; however, generally it is considered that the site of action should be the first unique enzyme in cholesterol synthesis. Conventionally this step is considered to be fl-hydroxy-,B-methylglutaryl-CoA reductase, but it is quite possible that acetyl-CoA is committed to cholesterol synthesis at the stage of cytoplasmic acetoacetyl-CoA thiolase. Thus 3-ketoacyl-CoA thiolase participates in two biosynthotic routes, namely cholesterol synthesis and ketone-body formation. Both of these synthetic routes involve the formation of ,6-hydroxy-fl-methylglutaryl-CoA from acetyl-CoA, which requires 3-ketoacyl-CoA thiolase and fl-hydroxy-.J-methylglutaryl-CoA synthase (Dempsey, 1974) . At this point the pathways diverge, and cholesterol synthesis requires fl-hydroxy-flmethylglutaryl-CoA reductase and ketone.body formation requires 8-hydroxy-/8-methylglutaryl-CoA lyase. Since fl-hydroxy-fl-methylglutaryl-CoA reductase is a microsomal enzyme (Siperstein, 1970 ) and fi-hydroxy"fl-methylglutaryl-CoA lyase is an intramitochondrial enzyme (Bucher etal., 1960; Dempsey, 1974) , this implies that f-hydroxy-fl-methylglutaryl..
CoA formation for cholesterol synthesis uses cytosolic acetoacetyl-CoA thiolase whereas for ketone.body formation mitochondrial 3-ketoacyl-CoA thiolase is required (Dempsey, 1974) . This means that in principle, an inhibitor which is specific for cytoplasmic acetoacetyl-CoA thiolase might only inhibit cholesterol synthesis and an inhibitor specific for mitochondrial 3-ketoacyl-CoA-thiolase might only in.. hibit ketone-body formation. Whether this degree of specificity can be achieved with the alk-3..ynoyl.
CoA esters is debatable and presumably will depend on (1) the susceptibility of the various isoenzymes of 3-ketoacyl-CoA thiolase to different inhibitor chain length, (2) the ability of the inhibitor to be converted into the CoA ester and (3) the distri,-bution of the resultant CoA ester within the cell.
One reservation to the possibility of using acetoacetyl-CoA thiolase as a target enzyme for inhibition of cholesterol synthesis is that mitochondrial 3-ketoacyl-CoA thiolase is an obligatory enzyme in ,8-oxidation. This raises the possibility that alkt3. ynoic acids may have the disadvantage of inhibiting fatty acid oxidation. A closely related inhibitor of 3-ketoacyl-CoA thiolase, penta-2,4-.dienoyl-.CoA, has been shown to inhibit mitochondrial oxidation (Holland & Sherratt, 1973; Holland et al., 1973b) .
1975
The consequences of an effect on fatty acid oxidation can only be ascertained by whole-animal studies.
In conclusion, suitably chosen acetylenic fatty acids act as selective inhibitors ofcholesterol synthesis in vitro and this may be of potential pharmacological importance if these effects can be produced in vivo. Certainly it is known that olefinic fatty acids have useful actions as hypocholesterolaemic agents and it will be interesting to establish whether the extra degree of unsaturation in acetylenic fatty acids will have any additional effects.
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